Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006911

Options or other derivatives

  • Chief Executive Officer acquired 525,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sullivan Eddie Joe Chief Executive Officer 2023-03-14 Grant or award · Employee Stock Option (right to buy) +525,000 525,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…